Published in Cancer Weekly, July 15th, 1996
Madhusudan V. Peshwa and colleagues at Activated Cell Therapy Inc., Mountain View California, report the development of a new protocol for the expansion and activation of CD8+ cytotoxic lymphocytes (CTLs).
Peshwa et al. reported their findings in the journal Biotechnology and Bioengineering ("Generation and Ex Vivo Expansion of HTLV-1 Specific CD8+ Cytotoxic T-Lymphocytes for Adoptive Immunotherapy," Biotech Bioeng, 1996;50:529-40).
"We have described a protocol for the generation and expansion of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.